TABLE 1.
Summary of patients with suspected PCNSL who underwent intra‐operative analysis by GeneSoC.
| Case | Sex | Age at diagnosis | Biopsy method | GeneSoC | ddPCR | Intra‐operative pathological diagnosis | Final diagnosis | ||
|---|---|---|---|---|---|---|---|---|---|
| Ct (WT) | Ct (L265P) | MYD88 status | MYD88 status | ||||||
| #1 | F | 55 | Endoscopic | 30.2 | 31.8 | L265P | L265P | na | DLBCL |
| #2 | M | 46 | Endoscopic | 34.4 | 39.2 | L265P | L265P | Malignant tumor (ML suspected) | DLBCL |
| #3 | M | 77 | Needle | 34.6 | na | WT | WT | Malignant tumor (ML or metastatic tumor suspected) | DLBCL |
| #4 | M | 40 | Endoscopic | 32.3 | 39.1 | L265P | L265P | na | DLBCL |
| #5 | F | 70 | Needle | 34.7 | 47.0 | L265P | L265P | na | DLBCL |
| #6 | F | 80 | Endoscopic | 32.3 | 36.6 | L265P | L265P | Malignant tumor | DLBCL |
| #7 | M | 70 | Endoscopic | 33.7 | 39.2 | L265P | L265P | Malignant tumor (ML suspected) | DLBCL |
| #8 | F | 80 | Endoscopic | 31.1 | na | WT | WT | Malignant tumor (ML suspected) | DLBCL |
| #9 | F | 72 | Endoscopic | 35.9 | 39.8 | L265P | L265P | Malignant tumor (ML suspected) | DLBCL |
| #10 | F | 45 | Endoscopic | 34.3 | 35.5 | L265P | L265P | na | DLBCL |
Abbreviations: DLBCL, diffuse large B cell lymphoma; ML, malignant lymphoma; na, not available.